Navigation Links
Bio-Matrix Scientific's Dr. O'Neill Sees University of Pittsburgh's,Published Study on Culture Blood-Forming Stem Cells from Human Fat,Tissue as Supporting Near Term Benefits of Banking Adipose (Fat),Derived Stem Cells

tissue.

Currently, Bio-Matrix is working towards opening its 15,000 square foot Stem Cell Banking facility. The focus of this facility will be the banking of Adipose (Fat) derived stem cells.

Dr. Geoffrey O'Neill received his Ph.D. in Immunology from the University of Glasgow in 1973. In 1974, he undertook post-doctoral training under the guidance of Dr. Robert A. Good (who performed the first bone marrow transplantation in a patient with immunodeficiency) at Memorial Sloan-Kettering Cancer Center in New York. Dr. O'Neill's field of study at Sloan-Kettering was transplantation immunobiology.

Dr. O'Neill has over twenty five years' experience in his field, achieving recognition from his colleagues as the recipient of the Jean Julliard Prize for Outstanding Research from the International Society of Blood Transfusion and International Society of Hematology, presented in Budapest, Hungary. He also received the JM Foundation Award, New York, for innovative research.

About Bio-Matrix Scientific Group

Bio-Matrix Scientific Group Inc. (www.BMSNonline.com) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation. Bio-Matrix' new 15,000 sq. ft. state-of-the-art facility, located in the heart of San Diego's biotechnology corridor, plans to open in September 2007. It will house Bio-Matrix' secure Cryogenic Stem Cell Bank, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories. The facility plans to cater to the growing stem cell research segment of the $75 billion biotechnology and medical
'"/>




Page: 1 2 3

Related medicine technology :

1. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
2. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
3. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
4. Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity
5. Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University
6. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
7. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
8. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/7/2009)...RNewswire/ -- Most patients with hereditary angioe...oncoming HAE attack giving the patients sufficient...dity associated with that attack, according to sur...College of Allergy, Asthma & Immunology (ACAAI...ch as fatigue and nausea, which occur frequently b...
(Date:11/6/2009)...RNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc....that is developing and marketing Levulan(®) P...ed on patients with common skin conditions, announ...Officer, will present a corporate overview at the ...ay, November 10, 2009 at 10:00 a.m. ET at the Hote...
(Date:11/6/2009)...wswire-FirstCall/ -- Roper Industries, Inc. (NYS...initive agreement to acquire Verathon, Inc., a lea... Verathon Board of Directors has approved the tran...gulatory approvals and closing conditions, includi...losing to be completed in early December. ,, H...
Breaking Medicine Technology:Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Independent Study 3A OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces 59330 1Independent Study 3A OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces 59330 2Independent Study 3A OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces 59330 3Ipsen and Debiopharm Group Announce That Decapeptyl 28R 29 28triptorelin embonate 29 6 month Successfully Completes the European Decentralised Procedu 14440 1Ipsen and Debiopharm Group Announce That Decapeptyl 28R 29 28triptorelin embonate 29 6 month Successfully Completes the European Decentralised Procedu 14440 2Ipsen and Debiopharm Group Announce That Decapeptyl 28R 29 28triptorelin embonate 29 6 month Successfully Completes the European Decentralised Procedu 14440 3Ipsen and Debiopharm Group Announce That Decapeptyl 28R 29 28triptorelin embonate 29 6 month Successfully Completes the European Decentralised Procedu 14440 4Ipsen and Debiopharm Group Announce That Decapeptyl 28R 29 28triptorelin embonate 29 6 month Successfully Completes the European Decentralised Procedu 14440 5Ipsen and Debiopharm Group Announce That Decapeptyl 28R 29 28triptorelin embonate 29 6 month Successfully Completes the European Decentralised Procedu 14440 6AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 1AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 2AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 3
... Hemolysis in PNH-Related Fatigue Presentation a...s, CHESHIRE, Conn., June 15 Soliris(R),(eculizum...xperienced by,patients with the rare blood disorde...ndent of improvements in anemia, according to data...ation (EHA) 13th Congress in,Copenhagen (abstract ...
... 13 Disc Motion Technologies,announced the comple...e,True Total Spinal Motion Segment System (TM) (TS...for the lumbar spine, featuring an artificial,lumb... (PDS). The,successful procedure was performed on ...ning Hospital by Dr. Erkan Kaptanoglu, Department ...
Other Medicine Technology:Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 3Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 4Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 5Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 6Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 7Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 8Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 9Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device 2
(Date:11/8/2009)...t mean the battle is won," said Dr. Charmaine Yoes...e/ -- In a vote of 240-194, the Stupak-Ellsworth-P... prohibit abortion mandates and funding in HR 3962... for Life Action President and CEO Dr. Charmaine Y...tory for the pro-life Americans across this countr...
(Date:11/8/2009)...RNewswire-USNewswire/ -- Pharmaceutical Research a...esident Ken Johnson released the following stateme..., "We are disappointed, but not surprised by tod...ardworking Americans as well as nearly half of the...voted against the bill. ,, "While well intentio...
(Date:11/8/2009)...assage of Health Care Reform Bill ,, Critical...verage for all Americans ,, CHICAGO, Nov. 7 /P...House of Representatives passed by a vote of 220-2...ould strengthen Medicare for seniors and end discr...ons of Americans out of affordable health coverage...
(Date:11/8/2009)...v. 8 March of Dimes hos...on to recognize prominent individuals who are cele...le models for March of Dimes commitment to improve...mes November Prematurity Awareness Month campaign,... the fight for preemies! ,, (Photo: http://ww...
(Date:11/7/2009)...ewswire-USNewswire/ -- The American Medical Associ...ward for Citizenship and Community Service to Manu... IL. The award recognizes physicians who have gone...to make an outstanding public service contribution...award today during the opening session of the 2009...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
...hers have been using baby talk with their children.../ople not to use baby talk as it may lead to delay... shows that mothers have been right all along! ...gets the attention of the child and actually helps...
...hich examined the tobacco byproducts in the urine ... fooling // themselves by thinking that they are g...g “light” or “ultra-light” cigarettes. No sign... was any difference in the levels of cotinine, a b...
...s proved that a new drug named histatin, a natural...fungus- Candida albicans,// which is responsible f...n that candidiasis, also known as thrush, is a dis...ems caused by antibiotics, chemotherapy or disease...
...ublished in New England Journal of Medicine, the r...may be spread from infected organ donor //to organ... recipients (kidneys, Liver, and arterial segment)...noculated mice with samples from the recipients. ...
...itamin E seemed to suggest that supplementing the ... heart problems. //Recently, a study published In ...reality of taking vitamin E supplements may be som...ers between 1993 and 1999, and the extended progra...
...tudy done in Greece to show the relationship of th...d up some interesting results.// The study took in... the plains and those living in the hills, data ta... villages in the lowlands and one in the mountains...
Other Medicine News:
... foot and ankle or deformity and leg lengthening c...ternal Fixation components are designed to reduce ...lexity of intra-operative and post-operative frame...ractors and hinges eliminate the need to stock lar...
Gold Standard Interference Screw
...g hip surgery. The Stulberg Hip Positioner is use... hip and revision surgery. It is designed to attac...isting table adapters. The upright pads are made ... and are sealed with a washable coating. The coati...
...fixation system for small bone orthopedic osteotom...ion and a superior screw and plating system in one...ag screws used for the fixation of the hand and fo...ed to overdrill the proximal segment while the low...
Medicine Products: